# HNI Corp: financial statements, quarterly

HNI · NYSE · CIK 48287 · [Materials](/sectors/materials.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/hni.md) · [Financials](/companies/hni/financials.md) · [Filings](/companies/hni/filings.md) · [Insiders](/companies/hni/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hni/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [712](/filings/0000048287-24-000193.md) | [680 d](/filings/0000048287-26-000084.md) | [588](/filings/0001628280-25-023236.md) | [624](/filings/0001628280-25-036323.md) | [672](/filings/0000048287-25-000137.md) | [643 d](/filings/0000048287-26-000084.md) | [600](/filings/0000048287-26-000100.md) | [667](/filings/0000048287-26-000125.md) | [684](/filings/0000048287-25-000137.md) | [888 d](/filings/0000048287-26-000084.md) | [1,348](/filings/0000048287-26-000100.md) | [1,472](/filings/0000048287-26-000125.md) |
| Cost of revenue | $m | [426](/filings/0000048287-24-000193.md) | [407 d](/filings/0000048287-26-000084.md) | [355](/filings/0001628280-25-023236.md) | [362](/filings/0001628280-25-036323.md) | [393](/filings/0000048287-25-000137.md) | [382 d](/filings/0000048287-26-000084.md) | [361](/filings/0000048287-26-000100.md) | [381](/filings/0000048287-26-000125.md) | [396](/filings/0000048287-25-000137.md) | [525 d](/filings/0000048287-26-000084.md) | [848](/filings/0000048287-26-000100.md) | [825](/filings/0000048287-26-000125.md) |
| Gross profit | $m | [285](/filings/0000048287-24-000193.md) | [273 d](/filings/0000048287-26-000084.md) | [233](/filings/0001628280-25-023236.md) | [261](/filings/0001628280-25-036323.md) | [279](/filings/0000048287-25-000137.md) | [260 d](/filings/0000048287-26-000084.md) | [238](/filings/0000048287-26-000100.md) | [286](/filings/0000048287-26-000125.md) | [288](/filings/0000048287-25-000137.md) | [364 d](/filings/0000048287-26-000084.md) | [500](/filings/0000048287-26-000100.md) | [647](/filings/0000048287-26-000125.md) |
| Selling, general and administrative | $m | [223](/filings/0000048287-24-000193.md) | [170 d](/filings/0000048287-26-000084.md) | [203](/filings/0001628280-25-023236.md) | [206](/filings/0001628280-25-036323.md) | [208](/filings/0000048287-25-000137.md) | [203 d](/filings/0000048287-26-000084.md) | [208](/filings/0000048287-26-000100.md) | [216](/filings/0000048287-26-000125.md) | [223](/filings/0000048287-25-000137.md) | [291 d](/filings/0000048287-26-000084.md) | [515](/filings/0000048287-26-000100.md) | [533](/filings/0000048287-26-000125.md) |
| Operating income | $m | [56.8](/filings/0000048287-24-000193.md) | [30.7 d](/filings/0000048287-26-000084.md) | [29.7](/filings/0001628280-25-023236.md) | [53.4](/filings/0001628280-25-036323.md) | [68.9](/filings/0000048287-25-000137.md) | [54.6 d](/filings/0000048287-26-000084.md) | [24.4](/filings/0000048287-26-000100.md) | [68.2](/filings/0000048287-26-000125.md) | [64.6](/filings/0000048287-25-000137.md) | [(31.2) d](/filings/0000048287-26-000084.md) | [(36.4)](/filings/0000048287-26-000100.md) | [92.1](/filings/0000048287-26-000125.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.6](/filings/0000048287-24-000193.md) | [0.0 d](/filings/0000048287-26-000084.md) | [4.3](/filings/0001628280-25-023236.md) | [10.0](/filings/0001628280-25-036323.md) | [14.3](/filings/0000048287-25-000137.md) | [11.2 d](/filings/0000048287-26-000084.md) | [5.0](/filings/0000048287-26-000100.md) | [13.8](/filings/0000048287-26-000125.md) | [16.2](/filings/0000048287-25-000137.md) | [1.6 d](/filings/0000048287-26-000084.md) | [(16.8)](/filings/0000048287-26-000100.md) | [20.1](/filings/0000048287-26-000125.md) |
| Net income | $m | [37.8](/filings/0000048287-24-000193.md) | [22.7 d](/filings/0000048287-26-000084.md) | [17.7](/filings/0001628280-25-023236.md) | [36.0](/filings/0001628280-25-036323.md) | [47.5](/filings/0000048287-25-000137.md) | [38.3 d](/filings/0000048287-26-000084.md) | [13.9](/filings/0000048287-26-000100.md) | [48.2](/filings/0000048287-26-000125.md) | [41.2](/filings/0000048287-25-000137.md) | [(49.2) d](/filings/0000048287-26-000084.md) | [(38.8)](/filings/0000048287-26-000100.md) | [51.1](/filings/0000048287-26-000125.md) |
| Diluted EPS | $ per share | [0.80](/filings/0000048287-24-000193.md) | not reported | [0.37](/filings/0001628280-25-023236.md) | [0.75](/filings/0001628280-25-036323.md) | [0.98](/filings/0000048287-25-000137.md) | not reported | [0.29](/filings/0000048287-26-000100.md) | [1.02](/filings/0000048287-26-000125.md) | [0.88](/filings/0000048287-25-000137.md) | not reported | [(0.55)](/filings/0000048287-26-000100.md) | [0.70](/filings/0000048287-26-000125.md) |
| Basic EPS | $ per share | [0.81](/filings/0000048287-24-000193.md) | not reported | [0.38](/filings/0001628280-25-023236.md) | [0.76](/filings/0001628280-25-036323.md) | [1.00](/filings/0000048287-25-000137.md) | not reported | [0.30](/filings/0000048287-26-000100.md) | [1.04](/filings/0000048287-26-000125.md) | [0.90](/filings/0000048287-25-000137.md) | not reported | [(0.55)](/filings/0000048287-26-000100.md) | [0.70](/filings/0000048287-26-000125.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [24.4](/filings/0000048287-23-000205.md) | [28.9](/filings/0000048287-25-000084.md) | [27.0](/filings/0000048287-24-000097.md) | [28.2](/filings/0000048287-24-000161.md) | [34.3](/filings/0000048287-24-000193.md) | [20.2](/filings/0000048287-26-000084.md) | [21.1](/filings/0001628280-25-023236.md) | [32.0](/filings/0001628280-25-036323.md) | [20.7](/filings/0000048287-25-000137.md) | [209](/filings/0000048287-26-000125.md) | [71.4](/filings/0000048287-26-000100.md) | [105](/filings/0000048287-26-000125.md) |
| Current assets | $m | [572](/filings/0000048287-23-000205.md) | [536](/filings/0000048287-25-000084.md) | [527](/filings/0000048287-24-000097.md) | [568](/filings/0000048287-24-000161.md) | [562](/filings/0000048287-24-000193.md) | [522](/filings/0000048287-26-000084.md) | [529](/filings/0001628280-25-023236.md) | [598](/filings/0001628280-25-036323.md) | [543](/filings/0000048287-25-000137.md) | [1,412](/filings/0000048287-26-000125.md) | [1,297](/filings/0000048287-26-000100.md) | [1,411](/filings/0000048287-26-000125.md) |
| Total assets | $m | [2,017](/filings/0000048287-23-000205.md) | [1,929](/filings/0000048287-26-000084.md) | [1,913](/filings/0000048287-24-000097.md) | [1,941](/filings/0000048287-24-000161.md) | [1,913](/filings/0000048287-24-000193.md) | [1,875](/filings/0000048287-26-000084.md) | [1,858](/filings/0001628280-25-023236.md) | [1,912](/filings/0001628280-25-036323.md) | [1,843](/filings/0000048287-25-000137.md) | [4,885](/filings/0000048287-26-000125.md) | [4,773](/filings/0000048287-26-000100.md) | [4,818](/filings/0000048287-26-000125.md) |
| Current liabilities | $m | [502](/filings/0000048287-23-000205.md) | [464](/filings/0000048287-25-000084.md) | [408](/filings/0000048287-24-000097.md) | [474](/filings/0000048287-24-000161.md) | [514](/filings/0000048287-24-000193.md) | [478](/filings/0000048287-26-000084.md) | [444](/filings/0001628280-25-023236.md) | [411](/filings/0001628280-25-036323.md) | [409](/filings/0000048287-25-000137.md) | [1,139](/filings/0000048287-26-000125.md) | [936](/filings/0000048287-26-000100.md) | [1,036](/filings/0000048287-26-000125.md) |
| Total liabilities | $m | [1,276](/filings/0000048287-23-000205.md) | [1,167](/filings/0000048287-25-000084.md) | [1,141](/filings/0000048287-24-000097.md) | [1,153](/filings/0000048287-24-000161.md) | [1,066](/filings/0000048287-24-000193.md) | [1,035](/filings/0000048287-26-000084.md) | [1,054](/filings/0001628280-25-023236.md) | [1,101](/filings/0001628280-25-036323.md) | [1,007](/filings/0000048287-25-000137.md) | [3,050](/filings/0000048287-26-000125.md) | [2,999](/filings/0000048287-26-000100.md) | [3,012](/filings/0000048287-26-000125.md) |
| Long-term debt | $m | [493](/filings/0000048287-23-000205.md) | [428](/filings/0000048287-25-000084.md) | [460](/filings/0000048287-24-000097.md) | [412](/filings/0000048287-24-000161.md) | [295](/filings/0000048287-24-000193.md) | [294](/filings/0000048287-26-000084.md) | [355](/filings/0001628280-25-023236.md) | [444](/filings/0001628280-25-036323.md) | [324](/filings/0000048287-25-000137.md) | [1,277](/filings/0000048287-26-000125.md) | [1,427](/filings/0000048287-26-000100.md) | [1,357](/filings/0000048287-26-000125.md) |
| Current portion of debt | $m | [15.4](/filings/0000048287-23-000205.md) | [7.5](/filings/0000048287-25-000084.md) | [12.8](/filings/0000048287-24-000097.md) | [50.7](/filings/0000048287-24-000161.md) | [50.9](/filings/0000048287-24-000193.md) | [50.3](/filings/0000048287-26-000084.md) | [50.0](/filings/0001628280-25-023236.md) | [0.0](/filings/0001628280-25-036323.md) | [0.0](/filings/0000048287-25-000137.md) | [16.2](/filings/0000048287-26-000125.md) | [18.3](/filings/0000048287-26-000100.md) | [18.1](/filings/0000048287-26-000125.md) |
| Shareholders' equity | $m | [741](/filings/0000048287-23-000205.md) | [761](/filings/0000048287-25-000084.md) | [772](/filings/0000048287-24-000097.md) | [788](/filings/0000048287-24-000161.md) | [847](/filings/0000048287-24-000193.md) | [840](/filings/0000048287-26-000084.md) | [804](/filings/0001628280-25-023236.md) | [811](/filings/0001628280-25-036323.md) | [836](/filings/0000048287-25-000137.md) | [1,836](/filings/0000048287-26-000125.md) | [1,774](/filings/0000048287-26-000100.md) | [1,805](/filings/0000048287-26-000125.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [123 d](/filings/0000048287-24-000193.md) | [105 d](/filings/0000048287-26-000084.md) | [(4.3)](/filings/0001628280-25-023236.md) | [51.3 d](/filings/0001628280-25-036323.md) | [129 d](/filings/0000048287-25-000137.md) | [51.2 d](/filings/0000048287-26-000084.md) | [12.6](/filings/0000048287-26-000100.md) | [31.1 d](/filings/0000048287-26-000125.md) | [155 d](/filings/0000048287-25-000137.md) | [77.4 d](/filings/0000048287-26-000084.md) | [(172)](/filings/0000048287-26-000100.md) | [140 d](/filings/0000048287-26-000125.md) |
| Capital expenditure | $m | [21.6](/filings/0000048287-24-000193.md) | [16.3 d](/filings/0000048287-26-000084.md) | [11.2](/filings/0001628280-25-023236.md) | [17.5](/filings/0001628280-25-036323.md) | [14.5](/filings/0000048287-25-000137.md) | [9.7 d](/filings/0000048287-26-000084.md) | [16.3](/filings/0000048287-26-000100.md) | [15.0](/filings/0001628280-25-036323.md) | [19.6](/filings/0000048287-25-000137.md) | [17.0 d](/filings/0000048287-26-000084.md) | [35.7](/filings/0000048287-26-000100.md) | not reported |
| Dividends paid | $m | [14.9 d](/filings/0000048287-24-000193.md) | [15.0 d](/filings/0000048287-26-000084.md) | [16.6](/filings/0001628280-25-023236.md) | [15.5 d](/filings/0001628280-25-036323.md) | [15.8 d](/filings/0000048287-25-000137.md) | [15.7 d](/filings/0000048287-26-000084.md) | [16.2](/filings/0000048287-26-000100.md) | [15.7 d](/filings/0000048287-26-000125.md) | [15.6 d](/filings/0000048287-25-000137.md) | [15.6 d](/filings/0000048287-26-000084.md) | [26.6](/filings/0000048287-26-000100.md) | [25.5 d](/filings/0000048287-26-000125.md) |
| Share repurchases | $m | [0.0 d](/filings/0000048287-24-000193.md) | [0.3 d](/filings/0000048287-26-000084.md) | [2.6](/filings/0001628280-25-023236.md) | [10.8 d](/filings/0001628280-25-036323.md) | [11.4 d](/filings/0000048287-25-000137.md) | [41.0 d](/filings/0000048287-26-000084.md) | [40.4](/filings/0000048287-26-000100.md) | [39.4 d](/filings/0000048287-26-000125.md) | [3.8 d](/filings/0000048287-25-000137.md) | [0.0 d](/filings/0000048287-26-000084.md) | [0.0](/filings/0000048287-26-000100.md) | [0.0 d](/filings/0000048287-26-000125.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [41.8](/filings/0000048287-23-000205.md) | [42.1](/filings/0000048287-24-000097.md) | [43.3](/filings/0000048287-24-000161.md) | [47.3](/filings/0000048287-24-000193.md) | [48.1](/filings/0001628280-25-023236.md) | [48.2](/filings/0001628280-25-036323.md) | [48.7](/filings/0000048287-25-000137.md) | [48.0](/filings/0000048287-26-000100.md) | [47.1](/filings/0000048287-26-000125.md) | [46.7](/filings/0000048287-25-000137.md) | [71.6](/filings/0000048287-26-000100.md) | [72.1](/filings/0000048287-26-000125.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 72,181,800 at 2026-07-04, from the cover of the [10-Q filed 2026-08-04](/filings/0000048287-26-000125.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.